ArticleTranslational andrology and urology2026
Combined anatomical parameters predict benign prostatic hyperplasia-related lower urinary tract symptom severity: a volume-stratified study.
Article in Translational andrology and urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The association between prostate volume (PV) and lower urinary tract symptoms (LUTS) in benign prostatic hyperplasia (BPH) is inconsistent, as significant symptoms frequently occur even with small prostates. Although ultrasonography noninvasively ascertains anatomical parameters, such as intravesical prostatic protrusion (IPP) and bladder neck angle (BNA), their predictive value across different prostate sizes remains unclear. We aimed to examine the association between prostatic anatomical parameters and the severity of LUTS in patients with BPH across different PV categories, and to develop a predictive model for voiding dysfunction based on these anatomical parameters. Methods: This retrospective study included 257 patients with BPH who visited The First Affiliated Hospital of Jinan University for LUTS between January 2023 and March 2024. Transrectal ultrasound was used to measure the PV, IPP, BNA, prostatic urethral angle (PUA), prostatic urethral length (PUL) and other anatomical parameters. Patients were stratified by PV (<30 Results: Of 257 patients with BPH, 91 (35.4%) and 166 (64.6%) belonged to the large-volume and small-volume groups, respectively. Multivariable linear regression revealed that, in small prostates, PUL (β=0.20), BNA (β=0.12) and age (β=0.11) independently predicted the International Prostate Symptom Score total score (IPSS-t), whereas PUL (β=-0.29) and BNA (β=-0.09) predicted Qmax. For large prostates, IPP (β=0.29), age (β=0.14), BNA (β=0.09), and PUA (β=0.08) predicted IPSS-t, whereas IPP (β=-0.21) and PUA (β=-0.09) predicted Qmax. Logistic regression demonstrated that the combination of IPP, BNA, and PUA constituted a significant predictor of voiding dysfunction (Qmax <10 mL/s) in patients with large PV. In the large-volume group, the combined model achieved an area under the curve (AUC) of 0.94 [95% confidence interval (CI): 0.90-0.99], which indicated robust discriminative power. Conclusions: Volume-stratified analysis provides a more precise assessment of prostate anatomical parameters in BPH. A model integrating IPP, BNA, and PUA demonstrates favorable accuracy in predicting voiding dysfunction specifically in large‑volume BPH. These findings underscore the clinical utility of ultrasonographic anatomical assessment and support volume‑stratified management. Prospective multicenter validation is required to translate this tool into practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.